rs1057516421
Variant summary
Our verdict is Likely pathogenic. The variant received 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000017.4(ACADS):c.1164_1165delTG(p.Glu389AspfsTer101) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,460,624 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000017.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- short chain acyl-CoA dehydrogenase deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae), G2P, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_pathogenic. The variant received 8 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000017.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| ACADS | TSL:1 MANE Select | c.1164_1165delTG | p.Glu389AspfsTer101 | frameshift | Exon 10 of 10 | ENSP00000242592.4 | P16219 | ||
| ACADS | c.1164_1165delTG | p.Glu389AspfsTer101 | frameshift | Exon 10 of 10 | ENSP00000616618.1 | ||||
| ACADS | c.1161_1162delTG | p.Glu388AspfsTer101 | frameshift | Exon 10 of 10 | ENSP00000563678.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000805 AC: 2AN: 248320 AF XY: 0.00000740 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1460624Hom.: 0 AF XY: 0.00000275 AC XY: 2AN XY: 726652 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 33
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.